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Abstract: The rat sciatic nerve has attracted widespread attention as an excellent model system for
studying autophagy alterations in peripheral neuropathies. In our laboratory, we have developed
an original rat model, which we used currently in routine novel drug screening and to evaluate
treatment strategies for chronic inflammatory demyelinating polyneuropathy (CIDP) and other
closely related diseases. Lewis rats injected with the S-palmitoylated P0(180-199) peptide develop
a chronic, sometimes relapsing-remitting type of disease. Our model fulfills electrophysiological
criteria of demyelination with axonal degeneration, confirmed by immunohistopathology and several
typical features of CIDP. We have set up a series of techniques that led us to examine the failures of
autophagy pathways in the sciatic nerve of these model rats and to follow the possible improvement of
these defects after treatment. Based on these newly introduced methods, a novel area of investigation
is now open and will allow us to more thoroughly examine important features of certain autophagy
pathways occurring in sciatic nerves.
Keywords: macroautophagy; chaperone-mediated autophagy; peripheral neuropathies; murine
models; rat sciatic nerve; CIDP
1. Introduction
Autophagy is a vital biological lysosome-mediated process that maintains cellular homeostasis by
degrading abnormal proteins and organelles. Three major types of autophagy have been recognized,
including macroautophagy, chaperone-mediated autophagy (CMA), and microautophagy [1,2].
Macroautophagy (often just called autophagy) is the most common form of autophagy, and during
this process, the cell forms a double-membrane sequestering compartment termed the phagophore,
which matures into the autophagosome. Following delivery to the vacuole or lysosome, the cargo
is degraded and the resulting macromolecules are released back into the cytosol for reuse [3,4].
CMA is the most selective type of autophagy, and involves the translocation of cytosolic proteins
containing a specific degradation signal (the KFERQ sequence motif) to the lysosomal lumen. This
motif, found in around 30% of cytosolic proteins, is usually buried in the fully folded protein
but can be exposed upon partial unfolding. It is recognized by HSPA8/HSC70 chaperone which,
together with other co-chaperones, targets the protein to the CMA adaptor (LAMP2A) localized
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on the lysosomal membrane. This interaction induces unfolding and translocation of the targeted
protein into the acidic lysosomal lumen, followed by their degradation by lysosomal enzymes, a large
family of enzymes that encompass some glycosidases, proteases (e.g., cathepsins), sulfatases, and
others [5–7]. Microautophagy is by far the least understood phenomenon. It is characterized by the
direct invagination of the lysosomal membrane to sequester cytoplasmic cargo [8,9]. This non-selective
lysosomal degradative process maintains organelle size, membrane homeostasis, and cell survival
under nitrogen restriction. Noticeably, these three main autophagy pathways—macroautophagy,
CMA, and microautophagy—are remarkably interconnected and further coordinated with other
self-eating pathways.
A number of recent studies tend to establish a link between possibly altered autophagy processes
and several autoimmune [10–17], and especially autoimmune, neurological diseases [18–21] (Table 1).
Table 1. Examples of autoimmune neurological diseases with autophagy abnormalities, and methods
and model systems used for investigating these conditions.
Neurological
Autoimmune Diseases Autophagy Abnormalities Methods
Model Systems or
Patient Samples Tested Ref.
Guillain–Barré
syndrome (GBS)
Increased Beclin-1 and MAP1LC3B
expression levels;
WB; TEM EAN rat (sciatic nerves) [22]
Increased MAP1LC3BII/I ratio;
Decreased expression of SQSTM1;
Increased formation
of autophagosomes
Chronic inflammatory
demyelinating
polyneuropathy (CIDP)
Increased Beclin-1 and
MAP1LC3B-II expression levels;
TEM; WB EAN rat (sciatic nerves) [19]Increased ratio MAP1LC3B-II/I;
Decreased expression of SQSTM1
Multiple sclerosis (MS)
Increased mRNA and protein level
of ATG5; qPCR; WB
EAE mice (blood) and
patient (blood and brain) [23]
Decreased expression of ATG16L2
and ATG9A genes; qPCR Patient (blood) [24]
Increased expression of ULK1 gene
Neuromyelitis optica
(NMO) Increased ATG5 variants
Mass array
system Patient (blood) [25]
Abbreviations: ATG, autophagy related-gene; EAE, experimental autoimmune encephalomyelitis; EAN,
experimental autoimmune neuritis; MAP1LC3B, microtubule-associated protein light chain 3; PCR, polymerase
chain reaction; qPCR, quantitative PCR; RNA, ribonucleic acid; SQSTM1, sequestosome-1; TEM, transmission
electron microscopy; ULK1, Unc-51 like-autophagy activating kinase 1; WB, western blotting.
However, it has not been well addressed whether autophagy is affected in
inflammatory/autoimmune peripheral neuropathies such as Guillain–Barré syndrome (GBS)
and chronic inflammatory demyelinating polyneuropathy (CIDP). GBS and CIDP are, respectively,
the human acute and chronic inflammatory demyelinating disorders of the peripheral nervous
system (PNS), which are clinically characterized by an involvement of proximal as well as distal
limb structures (weakness, paraesthesia). In these pathologies, the disease is presumably caused
by damage to the myelin sheath (i.e., a wrap of myelin that surrounds axons) of the peripheral
nerves [20,21]. The most widely used animal model of GBS is the experimental autoimmune neuritis
(EAN) and recently, we developed and characterized a new representative rat model for human CIDP,
the chronic-EAN [26,27]. Because the pathophysiology of GBS, and particularly of CIDP, remains
poorly understood, these models represent important tools to progress in the knowledge of the
pathogenesis of these diseases and for translational drug studies.
2. Rat Sciatic Nerve as a Valuable Model to Study Autophagy
The rat sciatic nerve is commonly studied by researchers working on peripheral neuropathies not
only for its anatomical features, but also for it length and consequently, the amount of tissue available
for immunohistochemical, western blotting, and PCR experiments, for example. Furthermore, it seems
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that it represents one of the first nerves to be committed in EAN and in chronic-EAN, adding value to
this model of choice.
In rats, the sciatic nerve originates from the fusion of spinal segments L4-L6 but principally from
L4 and L5 spinal nerves [28–30] to form the nerve on the lesser pelvis (Figure 1A). Only one study
demonstrated that the components of sciatic nerve from Sprague Dawley rats vary from L3 to L6 [31].
After the sciatic nerve has left the pelvis, it curves around the greater trochanter as a single fascicle
(considered as the proximal segment of the sciatic nerve), then takes a descending path to splits into
two and then into four fascicles. The segment immediately before the terminal branching is considered
the distal segment (Figure 1B).
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studies and adapted existing protocols to our specific material. Our work was also based on 
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As indicated above, there are nowadays no investigations on autophagy processes in GBS and 
CIDP. The only related study on inflammatory demyelinating polyneuropathies was made by 
immunoblotting in EAN, the animal model mimicking the classical monophasic acute form of GBS [19]. 
In this recent study, expression levels of autophagy markers Beclin-1, a component of the 
phosphatidylinositol-3-kinase complex that mediates vesicle-trafficking processes, and of 
microtubule-associated protein 1 light chain 3 (MAP1LC3B), a member of the highly conserved ATG8 
protein family were significantly increased. The MAP1LC3B-II/I ratio was also found to be increased. 
Concomitantly, as expected from these data, the expression level of sequestosome-1 (SQSTM1), also 
known as the ubiquitin-binding protein p62, was decreased in sciatic nerves of EAN rats compared 
with control rats. In full agreement, when examined by TEM, the formation of autophagosomes in 
axons and myelin sheaths of sciatic nerves in EAN rats was increased, compared with the control 
group. Together, these data suggest that autophagy activity is increased in the sciatic nerve of EAN 
rats. 
The rat sciatic nerve has also been used to study autophagy in other pathologies of the PNS such 
as peripheral nerve injury [39] and peripheral neuropathy occurring in patients with metabolic 
syndrome [37] and diabetes [38]. In these studies, it should be underlined that alterations evaluated 
in western blot of MAP1LC3B-I and -II, Beclin-1, ATG5 and ATG7 expression, and MAP1LC3B-II/I 
Figure 1. Dissection of rat sciatic nerves. (A) Ventral view of dissection and reference drawing made
from it, showing the segmental origins of sciatic nerve from Sprague Dawley strain (figure taken from
Rigaud et al. [30] with permission); (B) Sciatic nerve from a male Lewis rat aged nine weeks showing
removal sites of the proximal (P) and distal (D) segments.
Taking into consideration all these characteristics, the rat sciatic nerve undoubtedly represents
an adequate model for studying fundamental questions as the one we undertook to examine autophagy
in peripheral neuropathies. This area has been seldom investigated in sciatic nerves and therefore
there is very few examples of methodological precedent to rely on. However, there are many papers
describing appropriate techniques to assess autophagy and notably to measure the autophagy flux in
organs and diverse tissues [18,32–35]. Therefore, we took advantages of these studies and adapted
existing protocols to our specific material. Our work was also based on immunofluorescence and
western immunoblotting methods to test in rats the ex vivo alterations of molecules implicated in
autophagy [19,36–39]. Transmission electron microscopy (TEM) allows the monitoring of autophagic
vacuoles and autophagosomes [37–39].
As indicated above, there are nowadays no investigations on autophagy processes in GBS
and CIDP. The only related study on inflammatory demyelinating polyneuropathies was made
by immunoblotting in EAN, the animal model mimicking the classical monophasic acute form
of GBS [19]. In this recent study, expression levels of autophagy markers Beclin-1, a component
of the phosphatidylinositol-3-kinase complex that mediates vesicle-trafficking processes, and of
microtubule-associated protein 1 light chain 3 (MAP1LC3B), a member of the highly conserved ATG8
protein family were significantly increased. The MAP1LC3B-II/I ratio was also found to be increased.
Concomitantly, as expected from these data, the expression level of sequestosome-1 (SQSTM1), also
known as the ubiquitin-binding protein p62, was decreased in sciatic nerves of EAN rats compared
with control rats. In full agreement, when examined by TEM, the formation of autophagosomes in
axons and myelin sheaths of sciatic nerves in EAN rats was increased, compared with the control group.
Together, these data suggest that autophagy activity is increased in the sciatic nerve of EAN rats.
The rat sciatic nerve has also been used to study autophagy in other pathologies of the PNS
such as peripheral nerve injury [39] and peripheral neuropathy occurring in patients with metabolic
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syndrome [37] and diabetes [38]. In these studies, it should be underlined that alterations evaluated
in western blot of MAP1LC3B-I and -II, Beclin-1, ATG5 and ATG7 expression, and MAP1LC3B-II/I
ratio were demonstrated, whereas some variations of MAP1LC3B-I and -II expression only were
detected by immunofluorescence. TEM was used for detecting the presence of autophagosomes.
These observations further support the view that multiple methodological approaches have to be
combined to ascertain the eventual perturbations of autophagy in any tissues or naive biological
materials [34].
The aim of this short technical review is to summarize the contribution of different experimental
techniques used to study autophagy in ex vivo sciatic nerves from rats developing an immune
peripheral neuropathy.
2.1. Induction of CIDP in Rats
For inducing the disease, we use male Lewis rats, 7–8 weeks old, weighting 250–270 g.
They receive subcutaneously, at the base of the tail, 200 µL of an inoculum containing 200 µg
of S-palm-P0(180-199) peptide (sequence: Acetyl(palm)KRGRQTPVLYAMLDHSRS) and 0.5 mg of
M. tuberculosis (strain H37 RA, Difco, Detroit, MI, USA) emulsified in 100 µL of saline and 100 µL
of incomplete Freund’s adjuvant (Sigma-Aldrich, St. Louis, MO, USA) [26,27]. Rats that received
complete Freund’s adjuvant (CFA) alone are used as control. Body weight and clinical scores are
assessed daily from day 0 until day 60 days post-immunization. Severity of paresis is graded as
follows: 0—no illness; 1—flaccid tail; 2—moderate paraparesis; 3—severe paraparesis; 4—tetraparesis;
5—death (Figure 2).
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Figure 2. Visualization of clinical scores from male Lewis rat aged nine weeks. (A) Rat immunized 
with CFA and not developing clinical sign (clinical score of 0); (B) Rat immunized with S-palm-
P0(180-199) peptide plus CFA and developing CIDP (clinical score of 3). Abbreviations: CFA, 
complete Freund’s adjuvant; CIDP, chronic inflammatory demyelinating polyneuropathy. 
2.2. Immunofluorescence 
Immunofluorescence is a common laboratory technique, which is based on the localization of 
specific antigens using antibodies conjugated to fluorescent dyes (fluorochromes).  
CIDP is pathologically characterized by focal inflammatory demyelination followed by axonal 
degeneration. The prominent lymphoid cells in the lesion are macrophages, which actively contribute 
to the demyelinating process. Our rat model mimicking CIDP fulfils these features. It was exploited 
to investigate if an alteration of autophagy markers is present in macrophages, neurofilaments, or 
Schwann cells of Lewis rat sciatic nerves by co-localization studies of these markers.  
2.2.1. Procedure 
Rats are deeply anesthetized with Ketamine/Rompun and sciatic nerves are dissected out, fixed 
in Bouin-Hollande solution and embedded in paraffin. Staining is performed on 5-μm cross-sections. 
After dewaxing, nonspecific binding sites are blocked with 5% (v/v) horse serum (Vector 
Laboratories, Burlingame, CA, USA) in phosphate-buffered saline (PBS) pH 7.4 for 30 min at room 
temperature (RT). Sections are then incubated for 1 h at RT with primary antibodies against 
MAP1LC3B (5 μg/mL; MBL, Nagoya, Japan), LAMP2A (5 μg/mL; Abcam, Cambridge, UK), and 
SQSTM1 (5 μg/mL; Abcam) for visualizing autophagy in double immunostaining with neurofilament 
Figure 2. Visualization of clinical scores from male Lewis rat aged nine weeks. (A) Rat immunized with
CFA and not developing clinical sign (clinical score of 0); (B) Rat immunized with S-palm-P0(180-199)
peptide plus CFA and developing CIDP (clinical score of 3). Abbreviations: CFA, complete Freund’s
adjuvant; CIDP, chronic inflammatory demyelinating polyneuropathy.
2.2. Immunofluorescence
Immunofluorescence is a common laboratory technique, which is based on the localization of
specific antigens using antibodies conjugated to fluorescent dyes (fluorochromes).
CIDP is pathologically characterized by focal inflammatory demyelination followed by axonal
degeneration. The prominent lymphoid cells in the lesion are macrophages, which actively contribute
to the demyelinating process. Our rat model mimicking CIDP fulfils these features. It was exploited
to investigate if an alteration of autophagy markers is present in macrophages, neurofilaments, or
Schwann cells of Lewis rat sciatic nerves by co-localization studies of these markers.
2.2.1. Procedure
Rats are deeply anesthetized with Ketamine/Rompun and sciatic nerves are dissected out, fixed
in Bouin-Hollande solution and embedded in paraffin. Staining is performed on 5-µm cross-sections.
After dewaxing, nonspecific binding sites are blocked with 5% (v/v) horse serum (Vector Laboratories,
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Burlingame, CA, USA) in phosphate-buffered saline (PBS) pH 7.4 for 30 min at room temperature
(RT). Sections are then incubated for 1 h at RT with primary antibodies against MAP1LC3B (5 µg/mL;
MBL, Nagoya, Japan), LAMP2A (5 µg/mL; Abcam, Cambridge, UK), and SQSTM1 (5 µg/mL; Abcam)
for visualizing autophagy in double immunostaining with neurofilament 200 (NF200; 25 µg/mL;
Sigma-Aldrich), ED1 (1.25 µg/mL; Serotec, Oxford, UK), and S100 (a generous gift we received
from Said Ghandour, Strasbourg, France) for Schwann cells (Table 2). Antibody binding to tissue
sections is visualized with Alexa Fluor 488 or Cy3-conjugated secondary antibody (1:1200; Jackson
ImmunoResearch, West Grove, PA, USA) for 1 h at RT. Coverslips are mounted in AntiFade Poly-Mount
(4′,6-diamidino-2-phenylindole) medium (Polysciences Inc., Warrington, PA, USA) for MAP1LC3B
+ NF200 labeling, and in AntiFade Poly-Mount medium with 4′,6-diamidino-2-phenylindole (DAPI;
Polysciences Inc.) for the other labeling.
Table 2. References of antibodies used in our settings to analyze autophagy activity by IF and WB in
sciatic nerves from Lewis rats.
Antibody Supplier; References Technique (Concentration)
MAP1LC3B MBL; M186-3
IF (5 µg/mL)
WB (0.5 µg/mL)
SQSTM1 Abcam; ab109012
IF (5 µg/mL)
WB (0.5 µg/mL)
HSPA8 Abcam; ab21052 WB (0.5 µg/mL)
ATG12 Abcam; ab155589 WB (0.5 µg/mL)
LAMP2A Abcam; ab125068
IF (5 µg/mL)
WB (0.5 µg/mL)
Abbreviations: ATG, autophagy related-gene; HSPA8, heat shock 70 kDa protein 8; IF, immunofluorescence;
LAMP2A, lysosome-associated membrane protein 2; MAP1LC3B, microtubule-associated protein light chain
3; SQSTM1, sequestosome-1; WB, western blotting. Suppliers: Abcam, Cambridge, UK; MBL International
Corporation, Woburn, MA, USA.
Immunofluorescence staining is monitored with an Olympus BX60 fluorescent microscope and
images are captured with the digital camera DP7V. Other devices are equally effective. To obtain
quantitative analysis of the staining, in our experiments, the number of neurofilaments; macrophages;
Schwann cells; MAP1LC3B, LAMP2A, and SQSTM1 positive cells; and the number of double-labeled
spots are counted from a randomly selected 160 × 160 µm-area for MAP1LC3B labeling or
340 × 340 µm-area for the other labeling from five sections using the ImageJ software (Wayne Rasband,
National Institutes of Health, Rockville, MD, USA). Representative images of the number of stained
cells per mm2 are shown in Figure 3.
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2.2.2. Notes
Fixation with Bouin-Hollande solution is better than PFA because morphology and epitopes are
well preserved.
To reduce possible background, it is advisable:
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(1) to use normal horse serum or normal donkey serum as blocking agent in PBS-Tween (PBS-T)
rather than bovine serum albumin or fetal bovine serum;
(2) to use the primary antibodies in blocking solution;
(3) to use the secondary antibody in PBS-T and not in blocking solution;
(4) to wash in PBS and not in PBS-T.
It is crucial to fix the excised sciatic nerves very rapidly. As is well-known, fixation is critical for
preventing autolysis and preserving cells and tissue components. This fact precludes the possibility
of post-sawing incubation of neuronal tissues with lysosomal inhibitors for 4 h, which is required
to inhibit lysosomal enzymes and therefore, the autophagic flux cannot be measured in this setting.
The global autophagy markers expression levels only can be evaluated.
2.2.3. Advantages
One advantage of this method is that it allows the concomitant detection of two or three different
antigens in a cell or the identification of a specific cell in a tissue by two or three antibodies labeled
with different fluorophores, for example.
2.2.4. Limitations
Some drawbacks have to be mentioned. In particular, auto-fluorescence remains a technical
problem, which can produce false-positive results. Fluorochrome combinations must be carefully
considered to limit emission spectra overlaps, especially for the detection of co-localized proteins.
The fluorescence is not permanent and the photo bleaching phenomenon occurs as the samples are
exposed to the light of microscope.
2.3. Western Blotting
Western blotting is a technique used to separate, identify, and quantify the amount of proteins
present in cells or tissues, based on their respective molar mass by electrophoresis. Separated proteins
are transferred onto a membrane that is then incubated with antibodies specific to the protein of interest.
2.3.1. Procedure
Sciatic nerves are harvested, weighed, and homogenized with a tissue lyser in the so-called
radio-immunoprecipitation assay (RIPA) buffer (150 mM NaCl, 50 mM Tris, 1 mM ethylene diamine
tetraacetic acid (EDTA), 1% (v/v) Triton X-100, 0.5% (v/v) sodium deoxycholate, 0.1% (v/v) sodium
dodecyl sulfate (SDS), pH 8) supplemented with protease inhibitors (Roche, Mannheim, Germany).
Hundred µL of complete lysis buffer is added to 10 µg of tissue. Tissue homogenates are centrifuged
at 12,000 g for 10 min at 4 ◦C and the supernatant collected to measure the protein concentration
using the bi-cinchoninic acid assay Protein Assay Kit (Pierce Biotechnology, Rockford, IL, USA).
Laemmli buffer (pH 6.8; BioRad, Hercules, CA, USA) containing 5% (v/v) β-mercaptoethanol) is
added. Finally, lysates are denatured at 90 ◦C for 5 min and proteins (50 µg) are separated on a 4–20%
Tris-glycine SDS-polyacrylamide gel electrophoresis gradient gel (Mini-PROTEAN®TGX Stain-Free™
protein gels, BioRad, Hercules, CA, USA) and then transferred onto nitrocellulose membrane
(Trans-Blot®Turbo™ Transfer System, BioRad). Membranes are blocked with 3% (w/v) fat-free dry
milk in Tris-buffered saline (TBS; pH 9.6) containing 0.1% (v/v) Tween-20 (TBS-T) at RT for 1 h. After
one wash with TBS-T, antibodies specific to MAP1LC3B (0.5 µg/mL; MBL), SQSTM1 (0.5 µg/mL;
Abcam), ATG12-ATG5 (1 µg/mL; Abcam), HSPA8 (0.5 µg/mL; Abcam), and LAMP2A (1 µg/mL;
Abcam) are incubated overnight at 4 ◦C in TBS-T containing 1% (w/v) fat-free dry milk. After three
washes with TBS-T, membranes are incubated for 1 h at RT with horseradish peroxidase-conjugated
goat anti-mouse IgG fragment crystallizable (Fc) region-specific (50 ng/mL) and goat anti-rabbit
IgG Fc fragment specific secondary antibodies (25 ng/mL; both from Jackson ImmunoResearch).
After three further washes, a signal was detected using enhanced chemiluminescence reagent (BioRad)
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and Biorad-Chemiluminescence Imaging system. Protein levels are normalized by densitometry to
total protein using the Image LabTM Software (BioRad). Typical results are illustrated in Figure 4.
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Figure 4. Western immunoblot analysis of sciatic nerve extracts from two adult Lewis rats R1 and R2. 
(A) Expression of autophagy markers MAP1LC3B, SQSTM1, ATG12, HSPA8, and LAMP2A; (B) Total 
protein used as normalization control visualized by stain-free technique; (C) Quantification of protein 
expressed as normalized volume (intensity). 
2.3.2. Notes 
Once sciatic nerves are dissected out, they must be immediately frozen at least at −80 °C until 
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Figure 4. Western immunoblot analysis of sciatic nerve extracts from two adult Lewis rats R1 and R2.
(A) Expression of autophagy markers MAP1LC3B, SQSTM1, ATG12, HSPA8, and LAMP2A; (B) Total
protein used as normalization control visualized by stain-free technique; (C) Quantification of protein
expressed as normalized volume (intensity).
2.3.2. Notes
Once sciatic nerves are dissected out, they must be immediately frozen at least at −80 ◦C until
used. As is well known, defrosted samples are very sensitive to proteolytic degradation. As a result,
it is not possible to introduce lysosomal inhibitors that should be added in half of the samples
for 4 h to evaluate the autophagic flux and the total MAP1LC3B or SQSTM1 expression levels
only can be measured at each given time. RIPA lysis buffer is better than lysis buffer (50 mM
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 5 mM EDTA, 50 mM NaCl, containing
1% (v/v) Triton X-100, pH 7.4) because the amount of protein is more important. In our case, for the
extraction of proteins from sciatic nerves, the utilization of a tissue lyser is better than using a Polytron
or a potter homogenizer or than grounded to a power with a mortar and pestle in liquid nitrogen.
In fact, with these last techniques, there is a significant loss of material and thus of protein.
Electrophoresis at 90 V for ~15 min and then at 120 V for ~1.5 min is essential to obtain correct
bands signal when 50 µg of protein are charged. If a more important voltage is used, a band with
a wave effect will be obtained.
Using TBS-T for blocking and dilution solution is better than PBS-T because background
is reduced.
2.3.3. Advantages and Limitations
Advantages of western blotting include:
• sensitivity (detection of small protein amounts);
• quantification of the amount of protein.
The limitations of western blotting are:
• high cost, time, and technical demand;
• requirement of numerous experimental optimizations (protein extraction, lysis buffer, blocking
buffer, etc.);
• unexpected results: no bands, weak signal, unexpected or unusual bands, high background, etc.
2.4. TEM
TEM is an analytical method allowing visualization and analysis of specimens in the realms of
microspace. It utilizes energetic electrons to provide morphologic, compositional, and crystallographic
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information. This technique has not yet been used in our laboratory to visualize autophagosomes but
has been used by other researchers/research teams [22,34,37–39].
2.4.1. Procedure
Sciatic nerves are quickly removed and fixed with glutaraldehyde at a concentration from 2 to 3%
(v/v) in the presence or not of 1% (v/v) of paraformaldehyde in 0.1 M PBS at 4 ◦C between 2 h and
overnight. Then, the samples are post-fixed in 1% (w/v) osmium tetroxide in PBS for 1 h–1.5 h at 4 ◦C
rinsed in PBS, dehydrated in a graded series of alcohol and propylene oxide, and embedded in Epon
epoxy resin and polymerized at 60 ◦C for 48 h. Ultrathin sections (60–80 nm) are mounted on copper
grids, contrasted with uranyl acetate and lead citrate, and visualized using a transmission electron
microscope [22,34,37–39] (Figure 5).
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Numerous autophagosomes (arrows) were found within the myelinated and unmyelinated nerve 
fibers and in Schwann cells of WOKW rats sciatic nerves; (D) Myelinated and unmyelinated nerve 
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Figure 5. Ultrastructural images of sciatic nerves of five-month-old LEW.1W and WOKW rats. (A–C)
Numerous autophagosomes (arrows) were found within the myelinated and unmyelinated nerve fibers
and in Schwann cells of WOKW rats sciatic nerves; (D) Myelinated and unmyelinated nerve fibers
visualized in sciatic nerves of LEW.1W rats (figures taken from Kosacka et al. [37] with permission).
Abbreviations: LEW.1W, Lewis 1W; MF, myelinated fiber; SC, Schwann cells; UF, unmyelinated fibers;
WOKW, Wistar Ottawa Karlsburg W.
2.4.2. Note
According to our experience for other types of analysis, we recommend cutting transverse
sections of sciatic nerves after glutaraldehyde fixation, especially if an analysis of myelin and axons is
planned. Immunoelectron microscopy can be used to precisely evaluate the quantity and localization
of autophagic markers MAP1LC3B and SQSTM1 at specific time points.
2.4.3. Advantages and Limitations
TEM is advantageous due to its powerful magnification, which can visualize intracellular details.
However, there are also limitations to this approach: preparation of tissues or cells is very elaborate and
lengthy, and the technique is very expensive. During the sample preparation process, human errors
may lead to artifacts (e.g., the membrane continuity may be altered, organelles may be distorted or
disorganized, etc.) that the experimenter must be able to differentiate from the true specimen structure.
3. Conclusions
A number of comprehensive reviews and training materials have been published recently in the
field covered in the present article. They specially highlight the fact that several independent methods
have to be combined to adequately evaluate the autophagy activity status of considered cells and
eventually convince ourselves of possible failures in these processes. We also highly recommend using
a panel of these approaches as each presents specific bias, but when combined, they lead to data that
reinforce each other to bring safer interpretation.
The methods described in this short technical review remain relatively traditional [18,34].
However, they are totally novel with regard to the tissues that are analyzed. Autophagy research in
sciatic nerves is still in its beginning stages and further investigations will be crucial to precise the
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nature of defects occurring in diseases in which nerve cells of sciatic nerves are involved. Our hope is
also that these investigations lead to the discovery of new autophagy markers, which may contribute
detecting still unknown defects in some signaling circuits that might affect specific nerve cell subsets.
The application could also be particularly valuable to follow the success of novel therapies based on
molecules, peptides, biologics, or cells designed to target autophagy defaults in certain pathological
settings. In this frame, following autophagy markers in a validated, robust, and sensitive program
of relevant assays could be pertinent for managing stem cells—based treatments for sciatic nerve
injury, for example. Associated to other already established criteria, these new assays might therefore
contribute to a more accurate diagnosis of patients with peripheral neurological disorders, to a more
selective recruitment of patients enrolled into clinical trials and for making decisions regarding their
personalized treatment. It is worth remembering however that although pertinent animal models
show similarities with human disease, it is likely that immunological responses are different because
the complexity of human physiological immune system or because antigens involved in the pathology
are not the same between the two species. Therefore, extrapolation to human disease should always be
undertaken with caution and complementary studies need to be conducted.
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